Melanie Schwermer

Next‐generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in <i>MYCN‐</i>amplified neuroblastoma

Alexander Schramm, Johannes Köster, Tobias Marschall et al. · International Journal of Cancer · 2012 · 31 citations · Full text

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors

Melanie Schwermer, Sangkyun Lee, Johannes Köster et al. · Oncotarget · 2015 · 31 citations · Full text

Taraxacum officinale extract shows antitumor effects on pediatric cancer cells and enhance mistletoe therapy

Katrin Menke, Melanie Schwermer, Jennifer Felenda et al. · Complementary Therapies in Medicine · 2018 · 31 citations

Enhance Mistletoe Therapy, Oncology, Pediatric Cancer Cells +10

Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines

Melanie Schwermer, Michaela Hiber, Sabine Dreesmann et al. · Experimental Cell Research · 2018 · 31 citations · Full text

Anticancer Effects of &lt;b&gt;&lt;i&gt;Viscum album&lt;/i&gt;&lt;/b&gt; Fraxini Extract on Medulloblastoma Cells in vitro

Katrin Menke, Melanie Schwermer, Jürgen Eisenbraun et al. · Complementary Medicine Research · 2020 · 16 citations